Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VTC-G15 on Glucose Metabolism
NCT02518932Phase 1Unknown
- Start
- Mar 2015
- Primary completion
- Mar 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised trial in insulin resistance (IR) comparing VTC-G15 with Placebo (2 arms). Primary endpoint: Glucose Infusion Rate. Status: unknown.
02
Drugs
VTC-G15
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on NCT02518932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02518932.